Skip to main content

Currently Enrolling

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients with Gastroesophageal Reflux Disease while receiving Proton Pump Inhibitors
Currently enrolling

Purpose: To evaluate the safety and efficacy of IW-3718 in patients with Gastroesophageal Reflux Disease (GERD)
Principal Investigator: Nicholas Shaheen, MD MPH
Sponsor: Ironwood Pharmaceuticals, Inc.

Visit clinicaltrials.gov to learn more about this GERD Study

Phase 2, Multicenter, Open-Label, Extension Study to Evaluate the Safety and Tolerability of AK002 in Patients with Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis (AK002-003X/ENIGMA)

Currently enrolling by invitation only

Purpose: To evaluate the efficacy (eosinophil count) of AK002 in patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)
Principal Investigator: Evan Dellon, MD MPH
Sponsor: Allakos, Inc.

Visit clinicaltrials.gov to learn more about this ENIGMA Extension Study

 

Enrollment Closed

A Phase 2, Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients with Eosinophilic Gastritis with or without Eosinophilic Gastroenteritis (AK002-003)

Enrollment Closed
Purpose: To evaluate the efficacy (histological response) of AK002 in adults with Eosinophilic Gastritis (EG) with ir without Eosinophilic Gastroenteritis (EGE)
Principal Investigator: Evan Dellon, MD MPH
Sponsor: Allakos

Visit clinicaltrials.gov to learn more about the ENIGMA Study

Clinicaltrials.gov

 A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD), Protocol # CS-100

Enrollment Closed
Purpose: To demonstrate the safety and effectiveness of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System in the treatment of subjects with gastroesophageal reflux disease (GERD)
Principal Investigator: Dr. Nicholas J. Shaheen, MD, MPH
Sponsor: EndoStim

Visit clinicaltrials.gov to learn more about the EndoStim Study

Clinicaltrials.gov

 

 

Return to top of page


Please contact us for more information regarding any of the above active CEDAS research studies: